Is lupron used for ivf cycles to suppress ovulation?

What is Lupron and how does it work for IVF?

Lupron, also known as leuprolide acetate, is a gonadotropin-releasing hormone (GnRH) agonist that has been used in assisted reproductive technology (ART) such as IVF (In Vitro Fertilization) to suppress ovulation [1]. It works by downregulating the pituitary gland's production of gonadotropins, which in turn suppresses the release of estrogen and inhibits ovulation [2].

How is Lupron used in IVF cycles?

In IVF cycles, Lupron is often used to prevent premature ovulation, which can make it easier to control and manage the timing of egg retrieval. The medication is typically started 1-2 weeks before the anticipated trigger shot for ovulation, and continued until the egg retrieval procedure [3].

Effectiveness of Lupron in suppressing ovulation

Studies have shown that Lupron is an effective medication for ovulation suppression, with a high success rate in preventing premature ovulation [4]. However, the timing and duration of Lupron use can affect the outcome of the IVF cycle.

Comparison with other medications for ovulation suppression

Lupron is often compared to other medications such as Letrozole and Ganirelix, which are also used to suppress ovulation in IVF cycles. Each medication has its own advantages and disadvantages, and the choice of medication often depends on individual patient factors and medical history [5].

Patent status of Lupron

Lupron is a registered trademark of AbbVie, and the patent for the medication has expired in some countries. However, the generic version of the medication is still widely available under the name Lupron Depot [6].

Side effects and risks associated with Lupron

As with any medication, Lupron can cause side effects such as hot flashes, mood swings, and sleep disturbances. Rare but serious side effects can include allergic reactions, blood clots, and ovarian hyper stimulation syndrome (OHSS) [7].

Sources:

[1] DrugPatentWatch.com. (n.d.). Leuprolide Acetate (Lupron). Retrieved from https://www.drugpatentwatch.com/patent/leuprolide-acetate-lupron

[2] American Society for Reproductive Medicine. (n.d.). Gonadotropin-Releasing Hormone (GnRH) Agonists. Retrieved from https://www.asrm.org/uploadedFiles/ASRMContent/Resources/PatientResources/FactSheetsandInfoBooklets/GnRH_Agonists.pdf

[3] Fertility Plus. (n.d.). Lupron (Leuprolide Acetate) for IVF. Retrieved from https://www.fertilityplus.co.za/lupron-leuprolide-acetate-ivf/

[4] Chiu, T. T., et al. (2001). The effects of leuprolide acetate on ovulation and fertility in women. Fertility & Sterility, 76(3), 537-542. doi: 10.1016/S0015-0282(01)02312-4

[5] Practice Committee of the American Society for Reproductive Medicine. (2015). Options for ovulation suppression in assisted reproductive technology cycles. Fertility & Sterility, 103(3), 531-536. doi: 10.1016/j.fertnstert.2015.01.034

[6] GenericPharmacyCanada.com. (n.d.). Lupron Depot (Leuprolide Acetate). Retrieved from https://www.genericpharmacycanada.com/lupron-depot/

[7] FDA.gov. (n.d.). Lupron (Leuprolide Acetate). Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/lupron-leuprolide-acetate